Rezolute Inc RZ358 Phase 3 Planning Update Call Transcript
Hello and welcome to the Rezolute RZ358 Phase 3 planning update. (Operator Instructions) Please note, this event is being recorded. I would now like to turn the conference over to Nevan Elam, Chief Executive Officer and Founder. Please go ahead.
Thank you and good afternoon. I appreciate all of you joining us today for an update on the status of our Phase 3 program for RZ358. I am joined by our Chief Medical Officer, Dr. Brian Roberts, as well as our Vice President of New Product Planning, Jeff Roeseler.
Also joining us is Dr. Paul Thornton, a distinguished pediatric endocrinologist and senior author on the hyperinsulinism management guidelines, which will soon be published. Needless to say, Dr. Thornton is a globally recognized expert in the management of patients with congenital HI.
Before we go any further, I would like to make a note that during the course of this call and the Q&A period, we may make forward-looking statements regarding future events or future clinical development
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |